Clinical Trial Update: Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial PRESAP for prevention of colorectal sporadic adenomatous polyps has completed; the snippet notes the phase 3 status but does not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma

Snippet

Sponsor: Pfizer | Conditions: Colorectal Adenoma | Phase 3 | Status: COMPLETED